Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

37.77 +1.00 (+2.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,018,538
Open 38.23
Bid (Size) 37.80 (100)
Ask (Size) 38.00 (100)
Prev. Close 36.77
Today's Range 36.49 - 38.77
52wk Range 18.92 - 68.87
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Monster Stocks in the Making
There might still be time to get in on the ground floor. 
Via The Motley Fool
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term obesity and diabetes pipeline despite short-term setbacks. 
Via Stocktwits

Performance

YTD
-8.1%
-8.1%
1 Month
+11.4%
+11.4%
3 Month
-1.1%
-1.1%
6 Month
+33.5%
+33.5%
1 Year
-40.0%
-40.0%

More News

Read More
Is There a Future for Viking Therapeutics?
Via The Motley Fool
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Via Investor's Business Daily
Topics Government
Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years?
Via Stocktwits
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
Via Stocktwits
Earnings Preview For Viking Therapeutics
Via Benzinga
Druckenmiller's Viking Trade Just Hit A Golden Cross — And A Sweet 36% Gain
Via Benzinga
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils
Via Benzinga
Here's Why Shares in Viking Therapeutics Shot Higher in October
Via The Motley Fool
Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets.
Via The Motley Fool
Topics Artificial Intelligence
Prediction: The Next Eli Lilly Might Already Be Trading Under $50
Via The Motley Fool
Should You Buy Viking Therapeutics Before Nov. 5?
Via The Motley Fool
3 Promising Growth Stocks That Are Down Around 60% From Their Highs
Via The Motley Fool
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
Via Stocktwits
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Viking Therapeutics: High Risk, High Reward Play
Via MarketBeat
Here's Why This Obesity Drug Company's Share Price Soared Today
Via The Motley Fool
Topics Earnings
Why Is Viking Therapeutics Stock Rising Today?
Via Benzinga
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside
Via Stocktwits
Topics Artificial Intelligence
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies
Via Investor's Business Daily
Viking Therapeutics (NASDAQ:VKTX) Reports Q3 2025 Earnings Miss and 2.8% After-Hours Decline
Via Chartmill
Topics Earnings
Retail Investors' Top Stocks With Earnings This Week: Tesla, Netflix, Intel and More
Via Benzinga
Earnings Scheduled For October 22, 2025
Via Benzinga
These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond
Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 37.77
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 11/10/25 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.76B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.